Femoral Bone Metastases

Launched by UNIVERSITY HEALTH NETWORK, TORONTO · Sep 2, 2011

Keywords

ClinConnect Summary

This clinical trial is designed to study patients with cancer that has spread to the femur (the thigh bone) and who are at high risk of experiencing a fracture. Bone metastases can cause severe pain and make it difficult for patients to move around independently. The researchers aim to understand how different treatments, such as surgery or radiotherapy (a type of radiation treatment), affect patients' pain levels, mobility, and overall quality of life.

To be eligible for this study, participants must be at least 18 years old, have a confirmed diagnosis of cancer (excluding lymphoma), and show signs of femoral metastases that put them at high risk for fractures. The trial is currently recruiting participants, and those who join will receive treatment and be monitored for their recovery over the next several months. They will share their experiences regarding pain, ability to walk, and overall well-being, which will help doctors improve care for future patients with similar conditions.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Histologically confirmed diagnosis of malignancy other than lymphoma
• • Presence of femoral metastases at high risk of pathologic fracture (Mirels' score 8 or more)
• • At least 18 years of age
• • Able to provide written informed consent
• • Able to participate in follow-up
• Exclusion Criteria:
• • Surgical consultation for the purpose of obtaining a tissue/histological diagnosis only, not for treatment
• • Histological diagnosis of lymphoma